2026 Deenan Pillay: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	101	7925	7448	777	741	543	40667
Immunology	101	701	646	62	58	538	40651

Deenan Pillay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Deenan Pillay sits on this spectrum.

62 publications 807+

This scientist: 538 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Deenan Pillay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Deenan Pillay sits on this spectrum.

40 D-Index 157+

This scientist: 101 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Deenan Pillay is affiliated with University College London in the United Kingdom and has an extensive research profile primarily within the field of Medicine. Their work covers various subfields, including Infectious Diseases, Virology, General Health Professions, Oncology, and Epidemiology.

The scientist's main research topics include:

HIV/AIDS Research and Interventions
HIV Research and Treatment
COVID-19 and healthcare impacts
HIV/AIDS drug development and treatment
COVID-19 Clinical Research Studies
Adolescent Sexual and Reproductive Health
HIV, Drug Use, Sexual Risk

Pillay has contributed to several published works with notable papers including:

"Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study" (2020), published in The Lancet
"Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency" (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
"Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic" (2020), published in European Journal of Preventive Cardiology
"Quantifying HIV transmission flow between high-prevalence hotspots and surrounding communities: a population-based study in Rakai, Uganda" (2020), published in The Lancet HIV
"The changing role of funders in responsible research assessment: progress, obstacles and the way ahead" (2020), published in OPAL (Open@LaTrobe) (La Trobe University)

Frequently, Pillay has collaborated with co-authors such as Christophe Fraser, Amitava Banerjee, Laura Pasea, Mahdad Noursadeghi, and Bryan Williams, each contributing to multiple joint publications.

The scientist's research output is found prominently in venues including UNC Libraries, bioRxiv (Cold Spring Harbor Laboratory), The Lancet HIV, The Lancet, and the European Journal of Preventive Cardiology. UNC Libraries and bioRxiv show the highest number of publications.

Best Publications

Update of the Drug Resistance Mutations in HIV-1.

Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

1980
Citations
2011 update of the drug resistance mutations in HIV-1.

Johnson Va;Calvez;Günthard Hf;Paredes R

1246
Citations
Digital technologies in the public-health response to COVID-19.

Jobie Budd;Jobie Budd;Benjamin S. Miller;Erin M. Manning;Vasileios Lampos

1174
Citations
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

1133
Citations
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

B G Gazzard;Jane Anderson;Abdel Babiker;Marta Boffito

1051
Citations
2017 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

873
Citations
2014 Update of the drug resistance mutations in HIV-1.

Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson

841
Citations
2015 Update of the Drug Resistance Mutations in HIV-1.

Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

766
Citations
Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

664
Citations
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.

Amitava Banerjee;Amitava Banerjee;Laura Pasea;Steve Harris;Arturo Gonzalez-Izquierdo

527
Citations
Update of the Drug Resistance Mutations in HIV-1: 2005.

Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

525
Citations
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

492
Citations
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

Ravindra K Gupta;Michael R Jordan;Binta J Sultan;Andrew Hill

491
Citations
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie

487
Citations
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.

Dan Frampton;Dan Frampton;Dan Frampton;Tommy Rampling;Aidan Cross;Heather Bailey

466
Citations
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

Robert W. Shafer;Soo-Yon Rhee;Deenan Pillay;Veronica Miller

430
Citations
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

408
Citations
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

Rami Kantor;David A Katzenstein;Brad Efron;Ana Patricia Carvalho

392
Citations
Drug Resistance Mutations in HIV-1.

Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

360
Citations
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Ravindra K Gupta;Andrew Hill;Anthony W Sawyer;Alessandro Cozzi-Lepri

353
Citations

Frequent Co-Authors

David Dunn University College London

Caroline Sabin University College London

Andrew N. Phillips University College London

Frank Tanser University of Lincoln

Till Bärnighausen Heidelberg University

Tulio de Oliveira University of KwaZulu-Natal

Pontiano Kaleebu London School of Hygiene & Tropical Medicine

Kholoud Porter University College London

Nuala McGrath University of Southampton

Martin Fisher University of Sussex

External Links

Personal website of Deenan Pillay

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related online degrees can open doors to diverse healthcare careers. Many professionals transition into nursing roles to complement their immunology expertise, making programs like accelerated fnp highly attractive. These programs fast-track the journey to becoming a Family Nurse Practitioner, allowing graduates to provide advanced patient care.

For individuals without a nursing background, online absn programs for non nurses offer a practical pathway to enter the nursing field. These accelerated Bachelor of Science in Nursing programs enable quicker entry into healthcare roles, which is crucial for those eager to apply immunological knowledge practically.

Additionally, 12-month accelerated nursing programs provide an efficient route to obtain nursing credentials. The 12-month accelerated nursing programs are designed for motivated students looking to merge their science background with clinical practice swiftly.

For those seeking entry-level nursing roles, best easiest lpn programs to get into can be the ideal starting point. Licensed Practical Nurse programs offer a foundational healthcare role that complements immunology studies, providing practical experience in patient care and healthcare settings.